DXCM [NASD]
DexCom, Inc.
IndexS&P 500 P/E154.58 EPS (ttm)2.04 Insider Own0.50% Shs Outstand97.20M Perf Week305.91%
Market Cap28.87B Forward P/E68.07 EPS next Y4.64 Insider Trans-10.43% Shs Float96.41M Perf Month154.74%
Income211.70M PEG4.99 EPS next Q0.76 Inst Own96.40% Short Float3.46% Perf Quarter226.53%
Sales2.57B P/S11.22 EPS this Y-69.50% Inst Trans0.01% Short Ratio1.06 Perf Half Y94.16%
Book/sh22.52 P/B14.04 EPS next Y41.11% ROA4.40% Target Price546.94 Perf Year267.26%
Cash/sh29.44 P/C10.74 EPS next 5Y31.00% ROE10.10% 52W Range75.65 - 329.10 Perf YTD135.49%
Dividend- P/FCF305.16 EPS past 5Y31.70% ROI6.00% 52W High-3.94% Beta1.14
Dividend %- Quick Ratio4.80 Sales past 5Y33.70% Gross Margin68.50% 52W Low317.86% ATR22.26
Employees6300 Current Ratio5.30 Sales Q/Q24.50% Oper. Margin10.10% RSI (14)90.08 Volatility5.91% 6.24%
OptionableYes Debt/Eq0.93 EPS Q/Q68.00% Profit Margin8.20% Rel Volume0.29 Prev Close308.49
ShortableYes LT Debt/Eq0.93 EarningsApr 28 AMC Payout0.00% Avg Volume3.15M Price316.12
Recom1.80 SMA20198.83% SMA50177.78% SMA200151.05% Volume910,190 Change2.47%
Mar-02-22Resumed BofA Securities Buy $500
Feb-03-22Upgrade BTIG Research Neutral → Buy $535
Jan-19-22Upgrade Wells Fargo Equal Weight → Overweight $575
Jan-07-22Upgrade Guggenheim Neutral → Buy $580
Oct-18-21Downgrade Guggenheim Buy → Neutral
Jul-21-21Resumed Cowen Outperform $540 → $525
May-28-21Upgrade Wells Fargo Underweight → Equal Weight $380
May-25-21Initiated Barclays Overweight $500
Apr-15-21Initiated Atlantic Equities Overweight $438
Jan-06-21Upgrade UBS Neutral → Buy $410 → $445
Oct-02-20Downgrade Wells Fargo Equal Weight → Underweight $420 → $350
May-27-20Reiterated Piper Sandler Overweight $375 → $450
May-14-20Initiated Wells Fargo Equal Weight $420
Mar-05-20Initiated Citigroup Buy $330
Nov-07-19Upgrade Guggenheim Neutral → Buy
Nov-07-19Reiterated Canaccord Genuity Buy $185 → $195
Oct-23-19Initiated Stifel Buy
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
May-19-22 10:17AM  
08:44AM  
May-18-22 07:44AM  
May-11-22 11:07AM  
May-10-22 08:00AM  
May-03-22 07:15AM  
May-01-22 08:18AM  
Apr-29-22 03:45PM  
01:56PM  
06:59AM  
06:45AM  
04:00AM  
Apr-28-22 05:55PM  
05:27PM  
05:03PM  
04:03PM  
Apr-27-22 08:30AM  
07:13AM  
Apr-26-22 08:40AM  
08:39AM  
02:00AM  
Apr-25-22 09:47AM  
09:46AM  
Apr-22-22 09:51AM  
Apr-21-22 03:01PM  
09:16AM  
Apr-20-22 08:50AM  
Apr-19-22 12:45PM  
11:44AM  
09:32AM  
Apr-18-22 10:10AM  
Apr-14-22 10:44AM  
10:04AM  
Apr-11-22 12:16PM  
Apr-07-22 08:45AM  
Apr-05-22 10:04AM  
Apr-02-22 11:07AM  
Apr-01-22 03:29AM  
Mar-31-22 06:13PM  
04:15PM  
Mar-30-22 02:43PM  
Mar-29-22 09:05AM  
Mar-28-22 10:54AM  
Mar-25-22 09:00AM  
Mar-23-22 10:45AM  
Mar-18-22 10:00AM  
Mar-15-22 10:56AM  
Mar-14-22 04:13PM  
03:54PM  
01:39PM  
10:44AM  
09:33AM  
Mar-13-22 07:00AM  
Mar-12-22 10:45AM  
Mar-09-22 07:26AM  
Mar-07-22 06:00AM  
Mar-04-22 12:10PM  
Mar-02-22 06:24AM  
Mar-01-22 04:05PM  
Feb-28-22 06:00AM  
Feb-27-22 07:45AM  
Feb-26-22 07:44AM  
Feb-25-22 03:31AM  
Feb-20-22 07:00AM  
Feb-14-22 08:45AM  
Feb-11-22 10:56AM  
Feb-10-22 05:25PM  
04:03PM  
Feb-09-22 09:43AM  
Feb-08-22 10:15AM  
Feb-07-22 09:38AM  
Feb-04-22 08:27AM  
Feb-03-22 05:19PM  
03:01PM  
Feb-02-22 07:00PM  
Feb-01-22 06:15PM  
09:38AM  
07:00AM  
Jan-28-22 12:20PM  
08:21AM  
Jan-27-22 01:38PM  
Jan-26-22 05:38PM  
Jan-24-22 08:45AM  
Jan-20-22 09:21AM  
07:00AM  
Jan-19-22 08:56AM  
Jan-18-22 05:38PM  
01:38PM  
Jan-15-22 11:00AM  
07:14AM  
Jan-11-22 12:10PM  
09:30AM  
03:15AM  
Jan-10-22 07:45AM  
Jan-04-22 08:45AM  
Dec-28-21 08:15AM  
Dec-23-21 08:28AM  
Dec-20-21 10:57AM  
Dec-18-21 08:38PM  
Dec-17-21 09:15PM  
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patterson ChadEVP Global MarketingMay 09Sale342.77777266,33213,675May 10 04:11 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesApr 25Sale439.94250109,98535,425Apr 27 05:47 PM
Patterson ChadEVP, Global MarketingApr 11Sale498.75776387,03014,452Apr 13 04:43 PM
Regan Barry J.EVP Global OperationsMar 29Sale500.001,106553,00016,345Mar 30 05:49 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesMar 23Sale459.98250114,99535,675Mar 24 04:35 PM
Dolan Matthew VincentSVP Corporate DevelopmentMar 17Sale450.00484217,8006,634Mar 17 04:30 PM
Dolan Matthew VincentSVP Corporate DevelopmentMar 16Sale425.00686291,5507,118Mar 17 04:30 PM
SAYER KEVIN RChairman, CEO & PresidentMar 15Sale409.773,0001,229,29597,883Mar 17 04:29 PM
Dolan Matthew VincentSVP Corporate DevelopmentMar 15Sale412.411,016419,0097,804Mar 17 04:30 PM
Patterson ChadEVP, Global MarketingMar 10Sale401.27776311,38615,228Mar 14 04:22 PM
Selvaraj Shelly RamasamySVP Chief Information OfficerMar 10Sale401.272,366949,40511,454Mar 14 04:21 PM
Sylvain Jereme MEVP, Chief Financial OfficerMar 04Sale422.94600253,76414,662Mar 04 07:02 PM
Patterson ChadEVP, Global MarketingMar 01Sale413.974619,04312,528Mar 02 04:42 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesFeb 23Sale394.3325098,58234,370Feb 24 05:45 PM
SAYER KEVIN RChairman, CEO & PresidentFeb 14Sale418.043,0001,254,12094,617Feb 15 08:09 PM
KAHN BARBARADirectorFeb 10Sale442.354,6662,064,0143,000Feb 14 05:06 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesJan 24Sale416.77250104,19234,620Jan 26 04:27 PM
SAYER KEVIN RChairman, CEO & PresidentJan 18Sale435.5622,6749,875,80078,705Jan 20 05:35 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesDec 23Sale573.91250143,47834,870Dec 23 05:29 PM
SAYER KEVIN RChairman, CEO & PresidentDec 15Sale535.973,0001,607,89981,705Dec 17 04:22 PM
Regan Barry J.EVP OperationsDec 13Sale563.931,214684,61111,457Dec 14 04:15 PM
Sylvain Jereme MEVP, Chief Financial OfficerDec 06Sale517.59600310,55412,292Dec 06 07:16 PM
FOLETTA MARK GDirectorDec 01Sale562.83500281,41612,597Dec 02 05:53 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesNov 23Sale612.26250153,06540,579Nov 23 06:51 PM
Stern SadieEVP Chief Human Resources OffNov 23Sale612.261,195731,65111,790Nov 23 06:57 PM
Regan Barry J.EVP OperationsNov 22Sale638.65837534,55012,671Nov 23 06:57 PM
Stern SadieEVP Chief Human Resources OffNov 22Sale638.65856546,68412,985Nov 23 06:57 PM
SAYER KEVIN RChairman, CEO & PresidentNov 15Sale647.843,0001,943,51584,705Nov 16 01:11 PM
Collins Richard AlexanderDirectorNov 03Sale647.051,500970,5757,204Nov 29 06:36 PM
FOLETTA MARK GDirectorNov 01Sale626.32500313,16213,097Nov 02 05:13 PM
AUGUSTINOS NICHOLASDirectorOct 29Sale600.032,5001,500,087918Nov 02 05:12 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesOct 22Sale570.00250142,50040,829Oct 25 07:35 PM
SAYER KEVIN RChairman, CEO & PresidentOct 15Sale549.226,0003,295,33490,705Oct 18 07:35 PM
Patterson ChadEVP, Global MarketingOct 13Sale545.5414176,9219,603Oct 15 07:13 PM
FOLETTA MARK GDirectorOct 01Sale543.09500271,54713,597Oct 05 06:28 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesSep 23Sale573.346,7433,866,02041,079Sep 24 08:01 PM
SAYER KEVIN RChairman, CEO & PresidentSep 15Sale540.586,0003,243,46296,705Sep 16 07:01 PM
Patterson ChadEVP, Global MarketingSep 13Sale541.4715684,4699,744Sep 15 04:14 PM
Blackford Quentin S.Chief Operating OfficerSep 10Sale558.331,519848,10319,280Sep 10 04:15 PM
Flynn Paul REVP, Global RevenueSep 10Sale558.33626349,51510,928Sep 13 08:00 PM
Selvaraj Shelly RamasamySVP Information TechnologySep 10Sale558.33681380,22313,014Sep 13 08:19 PM
SAYER KEVIN RChairman, CEO & PresidentSep 09Sale541.363,0171,633,280102,705Sep 13 08:01 PM
Shrishrimal SumiSVP Chief Risk OfficerSep 09Sale541.37407220,33912,234Sep 13 08:01 PM
Sylvain Jereme MEVP, Chief Financial OfficerSep 09Sale541.36407220,33613,526Sep 13 08:01 PM
Selvaraj Shelly RamasamySVP Information TechnologySep 09Sale546.142,2231,214,05913,695Sep 13 08:19 PM
Balo Andrew K*Sep 09Sale546.785,5973,060,3377,553Sep 13 08:19 PM
Flynn Paul REVP, Global RevenueSep 09Sale541.36752407,10611,554Sep 13 08:00 PM
Leach Jacob StevenEVP Chief Technology OfficerSep 09Sale541.371,263683,74869,322Sep 13 08:00 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerSep 09Sale541.36987534,32716,254Sep 13 08:00 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesSep 09Sale541.371,263683,74747,822Sep 13 08:00 PM
Patterson ChadEVP, Global MarketingSep 09Sale541.37291157,5389,900Sep 13 08:00 PM
Abbey DonaldEVP Quality and Regulatory AffSep 09Sale541.371,263683,74748,674Sep 13 07:59 PM
Blackford Quentin S.Chief Operating OfficerSep 09Sale547.329,4625,178,69920,799Sep 10 04:15 PM
Blackford Quentin S.Chief Operating OfficerSep 08Sale545.877,6814,192,84630,261Sep 10 04:15 PM
Sylvain Jereme MEVP, Chief Financial OfficerSep 07Sale545.41587320,15613,933Sep 08 06:54 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerAug 26Sale517.24500258,62017,241Aug 27 06:38 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesAug 23Sale516.401,078556,67849,085Aug 25 04:59 PM
Balo Andrew K*Aug 03Sale515.872,7571,422,24710,652Aug 04 08:36 PM
Leach Jacob StevenEVP Chief Technology OfficerJul 30Sale476.7012,0875,761,87370,554Aug 02 06:19 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerJul 26Sale458.79500229,39517,741Jul 27 06:04 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesJul 23Sale452.181,079487,89750,163Jul 27 06:03 PM
Shrishrimal SumiSVP Chief Risk OfficerJul 16Sale450.00400180,00012,586Jul 16 08:40 PM
Balo Andrew K*Jul 06Sale430.142,9741,279,22813,409Jul 08 07:45 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerJun 28Sale431.49500215,74518,241Jun 29 07:05 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesJun 23Sale426.921,079460,65151,242Jun 24 05:59 PM
SKYLER JAY SDirectorJun 22Sale426.3720,0008,527,40613,968Jun 24 05:59 PM
Shrishrimal SumiSVP Chief Risk OfficerJun 11Sale401.09400160,43612,986Jun 15 06:14 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 09Sale395.0022,7558,988,22582,641Jun 10 05:43 PM
AUGUSTINOS NICHOLASDirectorJun 03Sale366.99806295,7943,110Jun 07 07:35 PM
Balo Andrew K*Jun 03Sale375.002,391896,62516,383Jun 07 07:33 PM
Blackford Quentin S.Chief Operating OfficerMay 28Sale375.007,2232,708,62537,942Jun 01 09:14 PM
Murphy Patrick MichaelEVP, Chief Legal OfficerMay 26Sale350.00500175,00018,741May 27 05:27 PM
Shrishrimal SumiSVP Chief Risk OfficerMay 25Sale354.791,461518,34813,386May 27 05:28 PM
Pacelli Steven RobertManaging Dir., Dexcom VenturesMay 24Sale348.711,079376,26052,321May 26 04:57 PM
Sylvain Jereme MEVP, Chief Financial OfficerMay 24Sale346.74600208,04414,508May 26 04:58 PM